It has been reported that the increased glucose metabolism caused by the upregulation of HK II can inhibit the activity of p53 (Han et al., 2019), which suggests that the high level of glycolysis in tumor cells may contribute to the downregulation of the antitumor effect of p53. The gene discussed is TP53; the disease is neoplasm.